These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effectiveness of paroxetine in the treatment of obsessive-compulsive disorders. Kamijima K; Aoki M Expert Rev Neurother; 2006 Jul; 6(7):945-56. PubMed ID: 16831110 [TBL] [Abstract][Full Text] [Related]
3. [Value of fluoxetine in obsessive-compulsive disorder in the adult: review of the literature]. Etain B; Bonnet-Perrin E Encephale; 2001; 27(3):280-9. PubMed ID: 11488259 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of antidepressant medications in children and adolescents with obsessive-compulsive disorder: a systematic appraisal. Gentile S J Clin Psychopharmacol; 2011 Oct; 31(5):625-32. PubMed ID: 21869690 [TBL] [Abstract][Full Text] [Related]
17. Clomipramine use in obsessive-compulsive disorder. Ivey JL; Rosenberg DR Expert Rev Neurother; 2002 Nov; 2(6):783-90. PubMed ID: 19810911 [TBL] [Abstract][Full Text] [Related]
18. Open trial of intravenous clomipramine in five treatment-refractory patients with obsessive-compulsive disorder. Fallon BA; Campeas R; Schneier FR; Hollander E; Feerick J; Hatterer J; Goetz D; Davies S; Liebowitz MR J Neuropsychiatry Clin Neurosci; 1992; 4(1):70-5. PubMed ID: 1627966 [TBL] [Abstract][Full Text] [Related]
19. Rapid benefit of intravenous pulse loading of clomipramine in obsessive-compulsive disorder. Koran LM; Sallee FR; Pallanti S Am J Psychiatry; 1997 Mar; 154(3):396-401. PubMed ID: 9054789 [TBL] [Abstract][Full Text] [Related]
20. Intravenous clomipramine for obsessive-compulsive disorder refractory to oral clomipramine: a placebo-controlled study. Fallon BA; Liebowitz MR; Campeas R; Schneier FR; Marshall R; Davies S; Goetz D; Klein DF Arch Gen Psychiatry; 1998 Oct; 55(10):918-24. PubMed ID: 9783563 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]